Global Brain Tumor Diagnosis And Therapeutics Market Size & Outlook
Global brain tumor diagnosis and therapeutics market, 2018-2030 (US$M)
Related Markets
Global brain tumor diagnosis and therapeutics market highlights
- The global brain tumor diagnosis and therapeutics market generated a revenue of USD 3,271.7 million in 2024 and is expected to reach USD 4,924.6 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 7.3% by 2030.
- In terms of segment, primary accounted for a revenue of USD 2,165.9 million in 2024.
- Secondary is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 3,271.7 million |
| Market revenue in 2030 | USD 4,924.6 million |
| Growth rate | 7.3% (CAGR from 2025 to 2030) |
| Largest segment | Primary |
| Fastest growing segment | Secondary |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Primary, Secondary |
Other key industry trends
- In terms of revenue, the North America accounted for 42.0% of the global brain tumor diagnosis and therapeutics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 59.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Brain Tumor Diagnosis And Therapeutics Market Scope
Brain Tumor Diagnosis And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Eisai Co Ltd | View profile | 11076 | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 | http://www.eisai.co.jp |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Shimadzu Corp | View profile | 15284 | 1, Nishinokyo-Kuwabara-cho, Nakagyo-ku, Kyoto, Japan, 604-8511 | http://www.shimadzu.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
Global brain tumor diagnosis and therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to brain tumor diagnosis and therapeutics market will help companies and investors design strategic landscapes.
Primary was the largest segment with a revenue share of 66.2% in 2024. Horizon Databook has segmented the Global brain tumor diagnosis and therapeutics market based on primary, secondary covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Brain Tumor Diagnosis And Therapeutics Type Outlook (Revenue, USD Million, 2018-2030)
- Primary
- Gliomas
- Astrocytomas
- Pituitary Tumors
- Meningioma
- Others Primary
- Secondary
- Primary
- Global Brain Tumor Diagnosis And Therapeutics Product Outlook (Revenue, USD Million, 2018-2030)
- Stains & Varnishes
- Lacquers
- Shellacs
- Others Product
- Global Brain Tumor Diagnosis And Therapeutics Diagnosis Outlook (Revenue, USD Million, 2018-2030)
- Tissue Sampling
- Others Diagnosis
- CT Scan
- PET-CT scan
- MRI
- Cerebral Arteriogram
- Molecular Testing
- EEG
- Lumbar Puncture
- Global Brain Tumor Diagnosis And Therapeutics Therapeutics Outlook (Revenue, USD Million, 2018-2030)
- Immunotherapy
- Others Therapeutics
- Radiation Therapy
- Surgery
- Chemotherapy
- Targeted Therapy
- Global Brain Tumor Diagnosis And Therapeutics End Use Outlook (Revenue, USD Million, 2018-2030)
- Others End Use
- Hospitals
- Oncology Treatment Centers
Reasons to subscribe to Global brain tumor diagnosis and therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global brain tumor diagnosis and therapeutics market databook
-
Our clientele includes a mix of brain tumor diagnosis and therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global brain tumor diagnosis and therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global brain tumor diagnosis and therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global brain tumor diagnosis and therapeutics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Brain tumor diagnosis and therapeutics market size, 2024 (US$M)
Global brain tumor diagnosis and therapeutics market share, by diagnosis, 2024 & 2030 (%, US$M)
Brain tumor diagnosis and therapeutics market: Opportunity assessment by country
Global brain tumor diagnosis and therapeutics market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
